Updated:
Blue Water Life Science Fund
Blue Water Life Science Fund invests in venture and growth-stage life science companies from hubs in Ann Arbor, San Francisco, Basel, and Singapore.
Blue Water Life Science Fund
Blue Water Life Science Fund focuses on venture and growth equity investments in the life sciences sector, with a geographic reach spanning North America, Europe, and Asia. The firm evaluates opportunities in biotechnology, pharmaceuticals, medical devices, and diagnostics. By maintaining offices in key global life science clusters including Ann Arbor, San Francisco, Basel, and Singapore, Blue Water positions itself to access proprietary deal flow and deep scientific networks. The investment strategy prioritizes companies developing transformative therapies and platform technologies. Blue Water typically participates in early-stage and growth-stage financings, often working alongside specialist life science venture firms and corporate venture arms. The firm's multi-hub structure allows it to diligence assets in both established and emerging biotech markets. No specific portfolio companies or fund sizes have been publicly confirmed as of mid-2026. Team size and assets under management are not publicly disclosed. The firm's office footprint suggests a globally distributed investment team with the ability to conduct on-the-ground due diligence in multiple regulatory environments. Philanthropic or adjacent vehicles have not been publicly identified in connection with the firm. Blue Water's structural anchor is its geography. Instead of concentrating in a single biotech capital, the firm maintains a deliberately distributed presence that mirrors the global nature of life science innovation — a model that differs from Boston- or San Francisco-centric peers. This architecture supports a sourcing funnel that draws from multiple academic, hospital, and entrepreneurial ecosystems simultaneously.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Ann Arbor
Corporate office
Ann Arbor, MI, United States
Additional offices
San Francisco, CA · Larkspur, CA · Minneapolis, MN · Singapore · Basel, Switzerland · Hong Kong
Sector focus
Frequently asked questions
What is Blue Water Life Science Fund's investment strategy?
Blue Water Life Science Fund pursues venture and growth equity investments in life sciences, covering biotechnology, pharmaceuticals, medical devices, and diagnostics. The firm evaluates companies developing novel therapeutics and platform technologies. Investment stages range from early venture to later growth rounds, typically participating alongside other specialist life science investors. Specific sector preferences or stage mandates have not been publicly detailed.
Where does Blue Water Life Science Fund invest geographically?
The firm invests across North America, Europe, and Asia. Its office locations — Ann Arbor, San Francisco, Larkspur, Minneapolis, Basel, and Singapore — reflect active coverage of multiple biotech ecosystems. This distributed footprint supports direct sourcing from academic medical centers, research institutions, and entrepreneurial clusters in each region.
How is Blue Water Life Science Fund structured?
Blue Water functions as a traditional investment management firm rather than a single family office or corporate venture arm. The firm raises capital from external limited partners to deploy into life science companies, though specific fund structures and vehicles have not been publicly disclosed. Its multi-office configuration suggests a partnership model with investment professionals distributed across its global locations.
Who runs investment decisions at Blue Water Life Science Fund?
The firm has not publicly disclosed its leadership team, investment committee structure, or named principals. With offices in six locations across three continents, decision-making authority is likely distributed among senior investment professionals in each region. No specific investment leads or managing partners have been identified in public record.
Does Blue Water Life Science Fund participate in fund commitments or only direct deals?
Public record indicates Blue Water focuses on direct venture and growth equity investments in life science companies rather than making fund commitments to other managers. The firm's direct investment posture aligns with its distributed office model, which supports hands-on sourcing and due diligence. No fund-of-funds activity has been attributed to the firm.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: